ARTICLE | Company News
PhotoBiotics deal
December 13, 2010 8:00 AM UTC
PhotoBiotics partnered with an undisclosed pharma to use PhotoBiotics' OptiLink antibody-drug conjugation (ADC) technology in a new indication. The platform uses small antibody fragments (scFvs) with ...